Skip to main content
    C

    CVS Health Corp (CVS)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $88.60
    -0.75 (-0.84%)

    Market Cap: $114.32B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    CVS Health Corp (CVS) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    CVS Health (CVS) trades at 10.6x trailing earnings and 0.3x sales. Its P/E of 10.6x is in line with its 5-year median. Its forward P/E is 10.6x. The median P/E across 12 similar companies is 18.6x.

    Current Multiples

    Its enterprise value is 8.9x its EBITDA. Its free cash flow yield is 13.7%.

    MultipleValue
    P/E (trailing)10.6x
    Forward P/E10.6x
    Price to sales0.3x
    Price to book1.4x
    EV/EBITDA8.9x
    Price to FCF7.3x
    EV/FCF11.3x
    PEG0.2
    FCF yield13.7%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 1.9% above 10.4x, its P/S is in line and its P/B is in line.

    MultipleCurrent5-year median10-year median
    P/E10.6x10.6x10.4x
    P/S0.3x0.3x0.3x
    P/B1.4x1.3x1.4x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 8.3x in 2024 to 13.5x in 2016.

    Year endPriceP/EP/SP/B
    2025$79.3611.8x0.3x1.3x
    2024$44.898.3x0.2x0.7x
    2023$78.969.0x0.3x1.3x
    2022$93.1910.6x0.4x1.7x
    2021$103.1612.3x0.5x1.8x
    2020$68.309.1x0.3x1.3x
    2019$74.2910.5x0.4x1.5x
    2018$65.529.3x0.3x1.2x
    2017$72.5012.2x0.4x2.0x
    2016$78.9113.5x0.5x2.3x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About CVS

    What is CVS's forward P/E ratio?

    CVS Health has a forward P/E ratio of 10.6x.

    Is CVS stock overvalued?

    GNG's valuation label for CVS is Fairly valued. Its P/E of 10.6x compares with a median of 18.6x across 12 similar companies.

    What is CVS's price to sales ratio?

    CVS Health has a price to sales ratio of 0.3x.

    What is CVS Health's average P/E ratio over 5 years?

    CVS Health's median P/E over the last 5 years is 10.6x, from 60 month-end values through Oct 2026.

    What is CVS's PEG ratio?

    CVS Health has a PEG ratio of 0.2.